The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sierra Oncology, Inc(NASDAQ:SRRA) 
Sierra Oncology, Inc. researches, develops, and commercializes therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is a selective and orally-bioavailable JAK1, JAK2, and ACVR1 inhibitor that has two completed Phase 3 trials for the treatm...
Website: http://www.sierraoncology.com
Founded: 2003
Full Time Employees: 69 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Sierra Oncology Days Receivable Outstanding ttm (DSO)
Sierra Oncology Op Cashflow Per Share ttm
Sierra Oncology Free Cashflow Per Share ttm
Sierra Oncology Cash Per Share ttm
Sierra Oncology P/S ratio ttm
Sierra Oncology (GAAP) P/E ratio ttm
Sierra Oncology P/B ratio ttm
No extra charts and metrics for this ticker.